PFE Pfizer, Inc. | US7170811035
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 59.373.166.570 | 61.746.012.640 | 3.84% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 2,83 | 2,94 | 3.74% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 24 | 25 | 4.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |